7-[2-[(2R,5R)-5-(4-amino-5-methylpyrrolo[2,3-d]pyrimidin-7-yl)thiolan-2-yl]ethyl]-3-bromoquinolin-2-amine
C22H23BrN6S — CID 166725025
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[2-[(2R,5R)-5-(4-amino-5-methylpyrrolo[2,3-d]pyrimidin-7-yl)thiolan-2-yl]ethyl]-3-bromoquinolin-2-amine
7-[2-[(2R,5R)-5-(4-amino-5-methylpyrrolo[2,3-d]pyrimidin-7-yl)thiolan-2-yl]ethyl]-3-bromoquinolin-2-amine (PubChem CID 166725025) has the molecular formula C22H23BrN6S and a molecular weight of 483.44 g/mol. Its IUPAC name is 7-[2-[(2R,5R)-5-(4-amino-5-methylpyrrolo[2,3-d]pyrimidin-7-yl)thiolan-2-yl]ethyl]-3-bromoquinolin-2-amine.
Molecular Properties
| Compound Name | 7-[2-[(2R,5R)-5-(4-amino-5-methylpyrrolo[2,3-d]pyrimidin-7-yl)thiolan-2-yl]ethyl]-3-bromoquinolin-2-amine |
|---|---|
| PubChem CID | 166725025 |
| Molecular Formula | C22H23BrN6S |
| Molecular Weight | 483.44 g/mol |
| Exact Mass | 482.09 |
| IUPAC Name | 7-[2-[(2R,5R)-5-(4-amino-5-methylpyrrolo[2,3-d]pyrimidin-7-yl)thiolan-2-yl]ethyl]-3-bromoquinolin-2-amine |
| SMILES | Cc1cn([C@H]2CC[C@@H](CCc3ccc4cc(Br)c(N)nc4c3)S2)c2ncnc(N)c12 |
| InChI | InChI=1S/C22H23BrN6S/c1-12-10-29(22-19(12)21(25)26-11-27-22)18-7-6-15(30-18)5-3-13-2-4-14-9-16(23)20(24)28-17(14)8-13/h2,4,8-11,15,18H,3,5-7H2,1H3,(H2,24,28)(H2,25,26,27)/t15-,18-/m1/s1 |
| InChIKey | JXKIWUFLPJUHKN-CRAIPNDOSA-N |
| XLogP | 5.24 |
| TPSA | 95.64 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.44 |
| LogP ≤ 5 | 5.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166725025 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.